ISPOR 20th Annual European Congress – 2017

  • November 4 - 8, 2017
    Glasgow, Scotland

    Short Course

    Using DICE Simulation for Health Economic Analyses

    Authors/Presenters: Caro JJ, Moller J

    Short Course

    Using Multi-Criteria Decision Analysis in Health Care Decision Making: Approaches & Applications

    Authors/Presenters: IJzerman M J, Marsh K, Devlin N

    Workshop

    W8: Modeling Separate Lines of Treatment Versus Treatment Sequences in Cancer

    Authors/Presenters: Benedict A, Stevenson M, Sorensen S

    Workshop

    W9: Patients' Preferences in the European Regulatory Environment: A Critical Review

    Authors/Presenters: Mühlbacher A, Marsh K, Van Til J

    Issue Panel

    IP11: Determining Value in Health Technology Assessment Consistent with Societal Aims: Pursue New Options?

    Authors/Presenters: Caro, JJ, McGuire A, Brazier J, Schlander M

    Issue Panel

    IP24: Trusting the Results of Model-Based Economic Analyses: Is There a Pragmatic Validation Solution?

    Authors/Presenters: Caro JJ, Stevenson M, Moller J, Ghabri S

    Issue Panel

    IP28: Patient Preferences in European Drug Regulation - Are We Ready?

    Authors/Presenters: Postmus D, Pignatti F, Demolis P, Tervonen T

    ISPOR Forum

    F2: Methods and Preliminary Results of the ISPOR Oncology Health Economic Modeling Special Interest Group

    Authors/Presenters: Muszbek N, Benedict A, Iannazzo S, Nabil Ashoush N, Qureshi H

    Podium Presentation

    RM3: Methods for Extracting Treatment Patterns for Renal Cell Carcinoma (RCC) From Social Media (SM) Forums Using Natural Language Processing (NLP) and Machine Learning (ML)

    Authors/Presenters: Merinopoulou E, Ramagopalan S, Malcolm B, Cox A

    Poster

    PCN46: A Systemic Literature Review of UK Epidemiology of BRCA1 and BRCA2-Mutated Locally Advanced Or Metastatic Ovarian Cancer

    Authors/Presenters: Bedel D, Ricci V, Sarri G, Lavaud V

    Poster

    PCN59: Matching Adjusted Indirect Comparison of Sunitinib and Everolimus for the Treatment of Pancreatic Neuroendocrine Tumours (PNETS)

    Authors/Presenters: Ishak J, Rael M, Hicks M, Mittal S, Eatock M, Valle JW

    Poster

    PCN163: Cost-Effectiveness of Ibrutinib in Patients with Relapsed OR Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England

    Authors/Presenters: Hassan F, Peng S, Dorman E, Sorensen S, Thompson G, Lee J

    Poster

    PCN165: Economic Evaluation of Nivolumab (NIVO) plus Ipilimumab (IPI) combination as First-line Treatment for Patients with Advanced Melanoma in Canada

    Authors/Presenters: Quon P, Xiao Y, Sorensen S, Schultz M, Tahami Monfared AA

    Poster

    PCN166: Modelling the Effectiveness of Ibrutinib Versus Physician's Choice (PC) in Relapsed OR Refractory (RR) Waldenstrom's Macroglobulinemia (WM) Within England

    Authors/Presenters: Guillermin A, Hassan F, Sydnor S, Peng S, Proskorovsky I, Sorensen S, Thompson G, Lee J

    Poster

    PCN200: Health State Utilities Associated with Treatment Options for Acute Myeloid Leukemia (AML)

    Authors/Presenters: Matza L, Deger K, Howell T, Hillgruber N, Yeager A, Hogge D, Fisher V, Louie A, Chung K

    Poster

    PCN221: Moving PRO Measures from the Promise to Impact in Oncology Clinical Practice: Results from a Systematic Literature Review

    Authors/Presenters: Anatchkova M, Skalicky AM, Whiteley J, Jagun D, McHorney C, Donelson SM

    Poster

    PDB37: Cost-Effectiveness Analysis of Empagliflozin in the Treatment of T2D with Previous Cardiovascular Disease in Italy

    Authors/Presenters: Iannazzo S, Mannucci E, Reifsnider O, Maggioni AP

    Poster

    PDB56: Evaluating Patients' Preferences for Dulaglutide Versus Insulin Glargine Profiles in the United Kingdom: A Discrete Choice Experiment

    Authors/Presenters: Norrbacka K, Poon JL, Boye K, Thieu VT, Hassan SW, Gelhorn HL

    Poster

    PUK18: Sentiment Analysis of Social Media Posts from Renal Cell Carcinoma (RCC) Patients

    Authors/Presenters: Merinopoulou E, Ramagopalan S, Malcolm B, Lees M, Cox A

    Poster

    PCV115: The Effect of Changing Utility Elicitation Methods in Cardiovascular Disease: A Systematic Literature Review

    Authors/Presenters: Betts M, Rane P, Bergrath E, Chitnis M, Gulea C, Qian Y, Villa G

    Poster

    PCV166: Real-World Treatment Patterns Among Patients Initiating on Statins in England

    Authors/Presenters: Lambrelli D, Merinopoulou E, Donaldson R, Mardekian J, Hlavacek P, Tarasenko L, Masseria C, Hobbs FDR

    Poster

    PGI4: Incidence of Surgery for Inflammatory Bowel Disease Within 12 Months of Initiation of Vedolizumab or Infliximab

    Authors/Presenters: Patel H, Raluy-Callado M, Berger A, Carroll R, Khalid JM

    Poster

    PMD105: Patient Preferences in Italy: Health State Utilities Associated with Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes

    Authors/Presenters: Matza L, Boye K, Jordan J, Norrbacka K, Gentilella R, Browne C, Federici M, Stewart K

    Poster

    PHP304: Challenges and Future Perspectives on the Reimbursement of Advanced Therapy Medicinal Products

    Authors/Presenters: Rothwell S, January D, Duda M, Gardner K, Michel S

    Poster

    PND35: Cost-effectiveness Analysis of PegInterferon Beta-1a vs. First-line Injectable Disease-Modifying Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis in Spain

    Authors/Presenters: Ruiz L, Toro-Diaz H, Cele C, Hernandez L, Harrington A

    Poster

    PND36: Cost-Effectiveness Analysis of Daclizumab Beta Versus Fingolimod for the Treatment of Multiple Sclerosis from a Spanish Payer Perspective

    Authors/Presenters: Ruiz L, Marchado M, Toro-Diaz H, Xaplanteris L

    Poster

    PND39: Cost-Effectiveness Analysis of Dimethyl Fumerate Versus Teriflunomide for the Treatment of Multiple Sclerosis

    Authors/Presenters: Ruiz L, Marchada M, Toro-Diaz H, Cele C, Hernandez L, Harrington A

    Poster

    PIN22: Budget Impact of Introducing Ceftazidime-Avibactam for Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections, and Hospital Acquired Pneumonia Including Ventilator-Associated Pneumonia to a Hospital Formulary in Italy

    Authors/Presenters: Kongnakorn T, Tichy E, Merinopoulou E, Berto P, Di Virgilio R, Charbonneau C

    Poster

    PRM13: Statistical Methods for Critical Care Outcomes

    Authors/Presenters: Exuzides A, Filonenko A, Kunz M, Gerlinger C, Chu BC, Bhurke S, Sites S

    Poster

    PRM62: Comparison of ICD-9 to ICD-10 Crosswalks Derived by Physician and Clinical Coder Vs. Automated Methods

    Authors/Presenters: Simeone J, Bhagnani T, Rhodes T, Reynolds M

    Poster

    PRM103: Representing Uncertainty in Economic Evaluations: Getting More from PSA Results

    Authors/Presenters: Oguz M, Lanitis T

    Poster

    PRM127: Incorporating Dependence Between Model Parameters in Uncertainty Analyses

    Authors/Presenters: Oguz M, Roiz J

    Poster

    PRM133: Calibrating Model-Consistent Transition Probabilities for Fibrosis Stages in NASH

    Authors/Presenters: Gal P, Roiz J, Xiao Y

    Poster

    PRM207: Minimizing Bias in Parametric Survival Analyses of Published Kaplan-Meier Curves

    Authors/Presenters: Rael M, Ishak J

    Poster

    PRM217: An Accessible Comparison of Traditional Statistical and Machine Learning Approaches to Analysis of Real World Data: Which, When and Why

    Authors/Presenters: Merinopoulou E, Oguz M, Chu BC, McDonald L, Ulvestad M, Cox A, Ramagopalan S

    Poster

    PRM218: Minimizing Bias in Indirect Comparisons Utilizing Virtual Patient Level Data

    Authors/Presenters: Rael M, Iskak J

    Poster

    PRM235: What's the Reality of Real-World Evidence in Health Technology Appraisal

    Authors/Presenters: Sarri G, Lambrelli D, Gulea C, Gomez Espinosa E, Iheanacho I

    Poster

    PRM253: A Robust, Reproducible Method for Evaluating the Suitability of Disparate Observational Databases for Pooled Analysis, Using the OMOP Common Data Model

    Authors/Presenters: Reisinger S, McDonald L, Carroll R, O’Hara D, Anstatt D, Ramagopalan S

Back to Top